chr19-39244423-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_172139.4(IFNL3):āc.252G>Cā(p.Gln84His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_172139.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFNL3 | NM_172139.4 | c.252G>C | p.Gln84His | missense_variant | 2/5 | ENST00000413851.3 | NP_742151.2 | |
IFNL3 | NM_001346937.2 | c.264G>C | p.Gln88His | missense_variant | 3/6 | NP_001333866.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFNL3 | ENST00000413851.3 | c.252G>C | p.Gln84His | missense_variant | 2/5 | 1 | NM_172139.4 | ENSP00000409000 | A2 | |
IFNL3 | ENST00000613087.5 | c.264G>C | p.Gln88His | missense_variant | 3/6 | 1 | ENSP00000481633 | P4 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459378Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 725806
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2023 | The c.252G>C (p.Q84H) alteration is located in exon 2 (coding exon 2) of the IFNL3 gene. This alteration results from a G to C substitution at nucleotide position 252, causing the glutamine (Q) at amino acid position 84 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at